SCHEMBL1385672

SCHEMBL1385672

C[C@@H]1CN(S(=O)(=O)c2nc3ccc(Cl)cc3[nH]2)CC(=O)N1CC1CCN(c2ccnc(N(C)C)n2)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 2/20 0.41
TRPC3 Q13507 1/20 0.37
KCNH2 Q12809 4/20 0.36
DGAT1 O75907 3/20 0.36
ALDH1A1 P00352 2/20 0.34
LMNA P02545 2/20 0.34
MAPT P10636 2/20 0.34
NPSR1 Q6W5P4 2/20 0.34
TRPV1 Q8NER1 1/20 0.34
HTT P42858 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
ADORA2A P29274 2/20 0.34
IDH1 O75874 1/20 0.34
ACACB O00763 1/20 0.33
PIK3CD O00329 1/20 0.33
PIK3CA P42336 1/20 0.33
PIK3CB P42338 1/20 0.33
CXCR3 P49682 2/20 0.32
USP2 O75604 1/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4397700 0.91 F10 (0.39) F10TRPC3KCNH2DGAT1ALDH1A1
SCHEMBL1385505 0.91 F10 (0.39) F10TRPC3KCNH2DGAT1ALDH1A1
SCHEMBL1384724 0.89 KCNH2 (0.39) F10TRPC3KCNH2DGAT1MAPT
SCHEMBL1386449 0.87 KCNH2 (0.39) F10KCNH2ACACBHTR7HTR6
SCHEMBL1384406 0.86 KCNH2 (0.45) F10KCNH2
SCHEMBL1385994 0.81 F10 (0.44) F10
SCHEMBL1386783 0.80 KCNH2 (0.40) F10KCNH2ACACB
SCHEMBL1385080 0.78 KCNH2 (0.45) F10KCNH2
SCHEMBL1385845 0.77 KCNH2 (0.46) F10KCNH2ACACB
SCHEMBL1386823 0.76 KCNH2 (0.52) F10KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4829449-B2 2011-12-07 JP claimed
JP-2003508353-A 2003-03-04 JP claimed
EP-1208097-A2 SUBSTITUTED OXOAZAHETEROCYCLYL COMPOUNDS Aventis Pharmaceuticals Inc. (US) 2002-05-29 EP claimed
WO-2001007436-A2 SUBSTITUTED OXOAZAHETEROCYCLYL COMPOUNDS AVENTIS PHARMACEUTICALS INC. (US) 2001-02-01 WO claimed
US-7612075-B2 Substituted oxoazaheterocyclyl compounds AVENTIS PHARMACEUTICALS INC. (US) 2009-11-03 US disclosed